Hospira Symbiq Infusion System
productEUA product tracked in the threat graph; the vulnerabilities below are known to affect it.
0
KEV-listed
0
public exploit
0
EPSS ≥ 10%
by severity
3critical2high0medium0low
updated 2026-10-28
01
vulnerabilities (5)
Related CVEs.
| ID | severity | exploitable |
|---|---|---|
| CVE-2015-3965US | high8.8 | — |
| CVE-2015-3954US | critical9.8 | — |
| CVE-2015-3953US | critical9.8OT elevated | — |
| CVE-2015-3952US | high7.5OT elevated | — |
| CVE-2015-3956US | critical9.8OT elevated | — |
02
weaknesses (8)
The flaw types (CWEs) most of these CVEs share.
- CWE-200Exposure of Sensitive Information to an Unauthorized Actor1 CVEs
- CWE-259Use of Hard-coded Password1 CVEs
- CWE-264CWE-2641 CVEs
- CWE-285Improper Authorization1 CVEs
- CWE-312Cleartext Storage of Sensitive Information1 CVEs
- CWE-345Insufficient Verification of Data Authenticity1 CVEs
- CWE-749Exposed Dangerous Method or Function1 CVEs
- CWE-798Use of Hard-coded Credentials1 CVEs
03
sources (2)
Which sources assert this record, and when.
- EUEU Vulnerability Database (ENISA)5 CVEs
- USCISA CSAF OT advisories (ICS)1 CVEs
scry
Products carry known vulnerabilities once they are exposed to the internet. See what is exposed on your perimeter with a free passive scan.
Free scan